MRKRMarker Therapeutics, Inc.vs its industry peers
A metric-by-metric comparison of Marker Therapeutics, Inc. against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| 기업 | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MRKR본 종목 | $20M#9 | — | 1.6x#5 | 5.5x#4 | -46.2%#4 | -13.3%#9 | -363.5%#3 | -100.0%#6 | -1413.6%#6 | — | 18.6%#1 | — |
| ACTU | $24M#1 | — | 24.3x#14 | — | — | 18.5%#6 | — | -2247.2%#14 | — | — | -85.6%#9 | — |
| LTRN | $23M#2 | — | — | — | — | 17.6%#7 | — | — | — | — | -54.3%#7 | — |
| CLRB | $23M#3 | — | 0.8x#3 | — | — | 51.1%#2 | — | -72.9%#5 | — | — | -54.7%#8 | — |
| TVRD | $23M#4 | — | 2.7x#8 | 3.2x#3 | -66.0%#5 | 38.1%#5 | -374.8%#4 | -217.3%#9 | — | — | -95.6%#11 | — |
| COCP | $21M#5 | — | 20.6x#13 | 10.7x#6 | -69.3%#6 | 49.5%#3 | -447.8%#5 | -845.9%#13 | -20.4%#1 | 3#2 | -15.2%#2 | — |
| AYTU | $21M#6 | — | 0.6x#2 | 0.3x#1 | 1.8%#3 | 14.4%#8 | -11.8%#1 | -38.6%#2 | -41.4%#2 | 4#1 | -15.7%#3 | — |
| RKTO | $20M#8 | — | 2.4x#7 | — | — | -52.3%#14 | — | -152.0%#7 | — | — | -53.7%#6 | — |
| SHPH | $20M#7 | 349.0x#3 | 6.1x#12 | — | — | -28.2%#10 | — | -350.3%#12 | -507.7%#4 | — | -90.3%#10 | — |
| ALLR | $19M#10 | 0.0x#1 | 5.4x#11 | 59.7x#8 | — | 54.2%#1 | -3939.1%#7 | -317.6%#11 | — | — | — | — |
| BFRI | $18M#11 | — | 3.1x#9 | 0.4x#2 | 11.7%#2 | 40.7%#4 | -27.2%#2 | -176.9%#8 | -712.4%#5 | — | — | — |
| ARTL | $18M#12 | — | 3.6x#10 | — | — | -31.1%#11 | — | -257.7%#10 | — | — | -97.0%#12 | — |
| LPCN | $17M#14 | — | 0.8x#4 | 8.8x#5 | -82.3%#7 | -96400.0%#15 | -524.7%#6 | -44.2%#4 | -52.6%#3 | — | -26.6%#4 | — |
| PTN | $18M#13 | 89.5x#2 | 1.7x#6 | — | -100.0%#8 | -41.8%#12 | — | 163.3%#1 | -2281.5%#7 | — | — | — |
| KTTA | $16M#15 | — | 0.3x#1 | 33.7x#7 | 3130.4%#1 | -46.9%#13 | -4286.7%#8 | -41.0%#3 | — | — | -33.4%#5 | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. 이 표는 생성 중 시간이 초과되어 그룹의 일부만 포함합니다. 순위는 표시된 행 내에서만 유효하며 곧 채워집니다. Table built 2026-09-17.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice